Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 2/2014

01-02-2014 | Editorial

Does higher hospital volume improve the patient outcome in acute pancreatitis?

Author: Masamichi Yokoe

Published in: Journal of Gastroenterology | Issue 2/2014

Login to get access

Excerpt

Over the past decade, many studies have shown a significant association between the volume of hospital services and patient outcomes for a wide variety of medical conditions [1‐3]. As regards acute pancreatitis, several population-based studies have shown higher hospital volume to be associated with better outcomes [4‐6]. Especially, a lower mortality rate, shorter length of hospital stay and lower total costs had been shown with higher hospital volume. However, acute pancreatitis has a wide range of severity and mortality; especially severe acute pancreatitis has a high mortality rate and longer length of hospital stay. …
Literature
1.
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346:1128–37.PubMedCrossRef
2.
Nathan H, Cameron JL, Choti MA, Schulick RD, Pawlik TM. The volume–outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship. J Am Coll Surg. 2009;208:528–38.PubMedCrossRef
3.
Thiemann DR, Coresh J, Oetgen WJ, Powe NR. The association between hospital volume and survival after acute myocardial infarction in elderly patients. N Engl J Med. 1999;340:1640–8.PubMedCrossRef
4.
Singla A, Simons J, Li Y, Csikesz NG, Ng SC, Tseng JF, et al. Admission volume determines outcome for patients with acute pancreatitis. Gastroenterology. 2009;137:1995–2001.PubMedCrossRef
5.
6.
Murata A, Matsuda S, Mayumi T, Yokoe M, Kuwabara K, Ichimiya Y, et al. Effect of hospital volume on clinical outcome in patients with acute pancreatitis, based on a national administrative database. Pancreas. 2011;40:1018–23.PubMedCrossRef
7.
Hamada T, Yasunaga H, Nakai Y, Isayama H, Horiguchi H, Fushimi K, Koike K. Impact of hospital volume on outcomes in acute pancreatitis: a study using a nationwide administrative database. J Gastroenterol. 2013;49(1):148–55.PubMedCrossRef
8.
Takeda K, Yokoe M, Takada T, Kataoka K, Yoshida M, Gabata T, et al. Assessment of severity of acute pancreatitis according to new prognostic factors and CT grading. J Hepatobiliary Pancreat Sci. 2010;17:37–44.PubMedCrossRef
9.
Hamada T, Yasunaga H, Nakai Y, Isayama H, Horiguchi H, Fushimi K, Koike K. Japanese severity score for acute pancreatitis well predicts in-hospital mortality: a nationwide survey of 17,901 cases. J Gastroenterol. 2013;48(12):1384–91.PubMedCrossRef
Metadata
Title
Does higher hospital volume improve the patient outcome in acute pancreatitis?
Author
Masamichi Yokoe
Publication date
01-02-2014
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 2/2014
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-013-0930-y

Other articles of this Issue 2/2014

Journal of Gastroenterology 2/2014 Go to the issue

Original Article—Alimentary Tract

A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury

Original Article—Alimentary Tract

Long-term incidence and characteristics of intestinal failure in Crohn’s disease: a multicenter study

Review

The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects

Erratum

Erratum to: A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury

Original Article—Alimentary Tract

Effects of ghrelin on gastric distension sensitive neurons and gastric motility in the lateral septum and arcuate nucleus regulation

Original Article—Alimentary Tract

C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits